Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change Price Change
grade C 243.86 0.33% 0.81
AGN closed up 0.33 percent on Friday, April 28, 2017, on 71 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: May 9

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical AGN trend table...

Date Alert Name Type % Chg
Apr 28 Doji - Bearish? Reversal 0.00%
Apr 28 Stochastic Reached Overbought Other 0.00%
Apr 27 Crossed Above 50 DMA Bullish 0.33%
Apr 27 Bollinger Band Squeeze Range Contraction 0.33%
Apr 27 Cup with Handle Other 0.33%
Apr 27 Expansion Pivot Buy Setup Bullish Swing Setup 0.33%
Apr 26 50 DMA Resistance Bearish 1.82%
Apr 26 Bollinger Band Squeeze Range Contraction 1.82%
Apr 26 Cup with Handle Other 1.82%
Apr 26 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.82%

Older signals for AGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 260.53
52 Week Low 183.98
Average Volume 2,572,523
200-Day Moving Average 228.2668
50-Day Moving Average 240.214
20-Day Moving Average 238.3815
10-Day Moving Average 238.275
Average True Range 3.0634
ADX 13.54
+DI 24.95
-DI: 16.3
Chandelier Exit (Long, 3 ATRs) 234.9598
Chandelier Exit (Short, 3 ATRs) 242.1902
Upper Bollinger Band 242.628
Lower Bollinger Band 234.135
Percent B (%b) 1.15
Bandwidth 0.035628